Abstract

http://ssrn.com/abstract=1625548
 
 

References (144)



 


 



Nanosilver and Global Public Health: International Regulatory Issues


Thomas Alured Faunce


Australian National University; Australian Research Council

Aparna Watal


Australian National University - ANU College of Law


Nanomedicine, Vol. 5, No. 4, pp. 617-632, 2010
ANU College of Law Research Paper No. 10-48

Abstract:     
Silver in nanoparticle form is used extensively worldwide in hospital and general practice settings in dressings as a treatment for external wounds, burns, and ulcers. Nanosilver also is an increasingly important coating over embedded medical devices, inhibiting the development of biofilm. Nanosilver disinfectant sprays and polymer coatings are being widely promoted as protective against viral infections. Nanosilver additionally is widely used for its anti-bacterial properties in food processing and packaging, as well as consumer products used for domestic cleaning and clothing.

This article argues that medical devices, therapeutic products and domestic food and goods containing nanosilver, though offering therapeutic benefits, must be subject to precautionary regulation because of associated public health and environmental risks, particularly from large volumes of nanosilver in waste water. It first examines the use of nanosilver in a variety of contemporary medical and domestic products and this utilization may assist in resolving global public health problems such as restricted access to safe food, water and medical care. It then discusses the mechanisms of toxicity for nanosilver, whether it should be classified as a new chemical entity for regulatory purposes and whether its increased usage poses significant environmental and public health risks. The article next critically analyses representative international regulatory regimes (the United States, European Union, United Kingdom and Australia) for medical and domestic use of nanosilver. The conclusion includes a set of recommendations for improving international regulation of nanosilver in terms of both its safety and potential positive contribution to global public health. Author's proof copy.

Number of Pages in PDF File: 17

Keywords: Nanosilver, Nanotechnology, Nanomedicine, Nanotoxicology, Public Health, Health Technology Regulation

JEL Classification: D63, D81, I18, K32, L65

Accepted Paper Series


Download This Paper

Date posted: June 16, 2010 ; Last revised: July 30, 2010

Suggested Citation

Faunce, Thomas Alured and Watal, Aparna, Nanosilver and Global Public Health: International Regulatory Issues. Nanomedicine, Vol. 5, No. 4, pp. 617-632, 2010; ANU College of Law Research Paper No. 10-48. Available at SSRN: http://ssrn.com/abstract=1625548

Contact Information

Thomas Alured Faunce (Contact Author)
Australian National University ( email )
Canberra, Australian Capital Territory 0200
Australia
61 2 61253563 (Phone)
Australian Research Council
Canberra, ACT 0200
Australia
Aparna Watal
Australian National University - ANU College of Law ( email )
Canberra, Australian Capital Territory 0200
Australia
Feedback to SSRN


Paper statistics
Abstract Views: 812
Downloads: 161
Download Rank: 106,451
References:  144

© 2014 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright   Contact Us
This page was processed by apollo3 in 0.375 seconds